Engineers Gate Manager’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-45,645
Closed -$56.1K 2148
2024
Q2
$56.1K Buy
45,645
+7,436
+19% +$6.67K ﹤0.01% 1807
2024
Q1
$30.3K Sell
38,209
-61,208
-62% -$55.7K ﹤0.01% 1829
2023
Q4
$94.7K Buy
+99,417
New +$97.6K ﹤0.01% 1786
2023
Q3
Sell
-77,111
Closed -$69.2K 1829
2023
Q2
$69.2K Buy
+77,111
New +$68.4K ﹤0.01% 1601
2023
Q1
Sell
-70,615
Closed -$65.6K 1688
2022
Q4
$65.6K Buy
70,615
+58,337
+475% +$77.8K ﹤0.01% 1528
2022
Q3
$21K Sell
12,278
-46,789
-79% -$123K ﹤0.01% 1535
2022
Q2
$126K Buy
59,067
+6,360
+12% +$16.9K ﹤0.01% 1707
2022
Q1
$187K Sell
52,707
-197,577
-79% -$573K 0.01% 1640
2021
Q4
$931K Buy
+250,284
New +$1.54M 0.04% 664
2021
Q2
Sell
-11,275
Closed -$85K 1656
2021
Q1
$85K Buy
+11,275
New +$127K ﹤0.01% 1724

Other funds holding CLOV

Engineers Gate Manager's CLOV Position: Q3 2024 in Review

Engineers Gate Manager sold out of Clover Health Investments (CLOV) in Q3 2024, closing a stake of 45,645 shares — an estimated $56.1K sold.

Engineers Gate Manager first reported a position in CLOV in Q1 2021 and held it in 10 quarters. The position peaked at $931K in Q4 2021. 159 funds tracked by Wall St. Rank hold CLOV as of Q3 2024.

  • Engineers Gate Manager reported no remaining Clover Health Investments position as of Q3 2024 after selling out during the quarter.
  • Engineers Gate Manager sold 45,645 Clover Health Investments shares in Q3 2024, an estimated $56.1K.
  • Engineers Gate Manager first reported a position in Clover Health Investments in Q1 2021 and held it in 10 quarters.
  • Engineers Gate Manager's Clover Health Investments position peaked at $931K in Q4 2021.
  • 159 funds tracked by Wall St. Rank held Clover Health Investments as of Q3 2024.

Based on Engineers Gate Manager's 13F filing for Q3 2024, filed 14 Nov 2024.